HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities research analysts at Roth Capital lifted their FY2025 earnings per share estimates for shares of HIVE Blockchain Technologies in a research report issued on Monday, January 6th. Roth Capital analyst D. Aftahi now anticipates that the company will post earnings per share of ($0.54) for the year, up from their prior forecast of ($0.55). Roth Capital has a “Strong-Buy” rating on the stock. Roth Capital also issued estimates for HIVE Blockchain Technologies’ Q1 2026 earnings at ($0.10) EPS, Q3 2026 earnings at ($0.04) EPS, FY2027 earnings at $0.23 EPS and FY2028 earnings at ($0.10) EPS.
A number of other analysts have also recently issued reports on HIV. Cantor Fitzgerald upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Tuesday, October 29th. Northland Capmk upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Thursday, September 19th.
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Further Reading
- Five stocks we like better than HIVE Blockchain Technologies
- Market Cap Calculator: How to Calculate Market Cap
- Why AMD Stock Might Already Be This Year’s Best Buy
- 10 Best Airline Stocks to Buy
- 3 Promising Penny Stocks to Watch for Long-Term Gains in 2025
- How to Buy Cheap Stocks Step by Step
- The 3 Kings of Buybacks in 2024: Can They Do It Again?
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
